BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 26356006)

  • 21. A complex interplay of genetic and epigenetic events leads to abnormal expression of the DUX4 gene in facioscapulohumeral muscular dystrophy.
    Gatica LV; Rosa AL
    Neuromuscul Disord; 2016 Dec; 26(12):844-852. PubMed ID: 27816329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Facioscapulohumeral Muscular Dystrophy.
    DeSimone AM; Pakula A; Lek A; Emerson CP
    Compr Physiol; 2017 Sep; 7(4):1229-1279. PubMed ID: 28915324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Small noncoding RNAs in FSHD2 muscle cells reveal both DUX4- and SMCHD1-specific signatures.
    Lim JW; Wong CJ; Yao Z; Tawil R; van der Maarel SM; Miller DG; Tapscott SJ; Filippova GN
    Hum Mol Genet; 2018 Aug; 27(15):2644-2657. PubMed ID: 29741619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic approach for FSHD revisited: SMCHD1 mutations cause FSHD2 and act as modifiers of disease severity in FSHD1.
    Larsen M; Rost S; El Hajj N; Ferbert A; Deschauer M; Walter MC; Schoser B; Tacik P; Kress W; Müller CR
    Eur J Hum Genet; 2015 Jun; 23(6):808-16. PubMed ID: 25370034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence.
    van der Maarel SM; Tawil R; Tapscott SJ
    Trends Mol Med; 2011 May; 17(5):252-8. PubMed ID: 21288772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammatory facioscapulohumeral muscular dystrophy type 2 in 18p deletion syndrome.
    Renard D; Taieb G; Garibaldi M; Maues De Paula A; Bernard R; Lagha N; Cristofari G; Vovan C; Chaix C; Lévy N; Khau Van Kien P; Sacconi S
    Am J Med Genet A; 2018 Aug; 176(8):1760-1763. PubMed ID: 30055030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Homozygous nonsense variant in
    Hamanaka K; Šikrová D; Mitsuhashi S; Masuda H; Sekiguchi Y; Sugiyama A; Shibuya K; Lemmers RJLF; Goossens R; Ogawa M; Nagao K; Obuse C; Noguchi S; Hayashi YK; Kuwabara S; Balog J; Nishino I; van der Maarel SM
    Neurology; 2020 Jun; 94(23):e2441-e2447. PubMed ID: 32467133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Facioscapulohumeral muscular dystrophy.
    Tawil R
    Handb Clin Neurol; 2018; 148():541-548. PubMed ID: 29478599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Facioscapulohumeral muscular dystrophy type 2: an update on the clinical, genetic, and molecular findings.
    Jia FF; Drew AP; Nicholson GA; Corbett A; Kumar KR
    Neuromuscul Disord; 2021 Nov; 31(11):1101-1112. PubMed ID: 34711481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deep characterization of a common D4Z4 variant identifies biallelic DUX4 expression as a modifier for disease penetrance in FSHD2.
    Lemmers RJ; van der Vliet PJ; Balog J; Goeman JJ; Arindrarto W; Krom YD; Straasheijm KR; Debipersad RD; Özel G; Sowden J; Snider L; Mul K; Sacconi S; van Engelen B; Tapscott SJ; Tawil R; van der Maarel SM
    Eur J Hum Genet; 2018 Jan; 26(1):94-106. PubMed ID: 29162933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SMCHD1 regulates a limited set of gene clusters on autosomal chromosomes.
    Mason AG; Slieker RC; Balog J; Lemmers RJLF; Wong CJ; Yao Z; Lim JW; Filippova GN; Ne E; Tawil R; Heijmans BT; Tapscott SJ; van der Maarel SM
    Skelet Muscle; 2017 Jun; 7(1):12. PubMed ID: 28587678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A proteomics study identifying interactors of the FSHD2 gene product SMCHD1 reveals RUVBL1-dependent DUX4 repression.
    Goossens R; Tihaya MS; van den Heuvel A; Tabot-Ndip K; Willemsen IM; Tapscott SJ; González-Prieto R; Chang JG; Vertegaal ACO; Balog J; van der Maarel SM
    Sci Rep; 2021 Dec; 11(1):23642. PubMed ID: 34880314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SMCHD1 is involved in de novo methylation of the DUX4-encoding D4Z4 macrosatellite.
    Dion C; Roche S; Laberthonnière C; Broucqsault N; Mariot V; Xue S; Gurzau AD; Nowak A; Gordon CT; Gaillard MC; El-Yazidi C; Thomas M; Schlupp-Robaglia A; Missirian C; Malan V; Ratbi L; Sefiani A; Wollnik B; Binetruy B; Salort Campana E; Attarian S; Bernard R; Nguyen K; Amiel J; Dumonceaux J; Murphy JM; Déjardin J; Blewitt ME; Reversade B; Robin JD; Magdinier F
    Nucleic Acids Res; 2019 Apr; 47(6):2822-2839. PubMed ID: 30698748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of epigenetic silencing of the DUX4 transcription factor gene in facioscapulohumeral muscular dystrophy.
    Hewitt JE
    Hum Mol Genet; 2015 Oct; 24(R1):R17-23. PubMed ID: 26113644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Individual epigenetic status of the pathogenic D4Z4 macrosatellite correlates with disease in facioscapulohumeral muscular dystrophy.
    Jones TI; King OD; Himeda CL; Homma S; Chen JC; Beermann ML; Yan C; Emerson CP; Miller JB; Wagner KR; Jones PL
    Clin Epigenetics; 2015; 7(1):37. PubMed ID: 25904990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical, muscle pathological, and genetic features of Japanese facioscapulohumeral muscular dystrophy 2 (FSHD2) patients with SMCHD1 mutations.
    Hamanaka K; Goto K; Arai M; Nagao K; Obuse C; Noguchi S; Hayashi YK; Mitsuhashi S; Nishino I
    Neuromuscul Disord; 2016; 26(4-5):300-8. PubMed ID: 27061275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying diagnostic DNA methylation profiles for facioscapulohumeral muscular dystrophy in blood and saliva using bisulfite sequencing.
    Jones TI; Yan C; Sapp PC; McKenna-Yasek D; Kang PB; Quinn C; Salameh JS; King OD; Jones PL
    Clin Epigenetics; 2014; 6(1):23. PubMed ID: 25400706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Genetics and Epigenetics of Facioscapulohumeral Muscular Dystrophy.
    Himeda CL; Jones PL
    Annu Rev Genomics Hum Genet; 2019 Aug; 20():265-291. PubMed ID: 31018108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allele-specific DNA hypomethylation characterises FSHD1 and FSHD2.
    Calandra P; Cascino I; Lemmers RJ; Galluzzi G; Teveroni E; Monforte M; Tasca G; Ricci E; Moretti F; van der Maarel SM; Deidda G
    J Med Genet; 2016 May; 53(5):348-55. PubMed ID: 26831754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemizygosity for SMCHD1 in Facioscapulohumeral Muscular Dystrophy Type 2: Consequences for 18p Deletion Syndrome.
    Lemmers RJ; van den Boogaard ML; van der Vliet PJ; Donlin-Smith CM; Nations SP; Ruivenkamp CA; Heard P; Bakker B; Tapscott S; Cody JD; Tawil R; van der Maarel SM
    Hum Mutat; 2015 Jul; 36(7):679-83. PubMed ID: 25820463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.